Does REGORAFENIB Cause Colorectal cancer? 236 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 236 reports of Colorectal cancer have been filed in association with REGORAFENIB (Stivarga). This represents 2.5% of all adverse event reports for REGORAFENIB.
236
Reports of Colorectal cancer with REGORAFENIB
2.5%
of all REGORAFENIB reports
70
Deaths
63
Hospitalizations
How Dangerous Is Colorectal cancer From REGORAFENIB?
Of the 236 reports, 70 (29.7%) resulted in death, 63 (26.7%) required hospitalization, and 9 (3.8%) were considered life-threatening.
Is Colorectal cancer Listed in the Official Label?
Yes, Colorectal cancer is listed as a known adverse reaction in the official FDA drug label for REGORAFENIB.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Colorectal cancer?
RANITIDINE (45,528)
VALSARTAN (193)
ADALIMUMAB (97)
INFLIXIMAB (79)
FLUOROURACIL (66)
PANITUMUMAB (65)
IRINOTECAN (60)
BEVACIZUMAB (57)
OXALIPLATIN (55)
TACROLIMUS (55)
Which REGORAFENIB Alternatives Have Lower Colorectal cancer Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR